COMMUNIQUÉS West-GlobeNewswire

Anaptys Announces $100 Million Stock Repurchase Plan
21/11/2025
SAN DIEGO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its Board of Directors [...]
Trading by management and close relations of management
21/11/2025
Please read the full announcement in PDF Attachment 2025_49_Trading_By_Management
Regional Health Properties Reports Third Quarter 2025 Results Following Completion of Merger with SunLink Health Systems, Inc.
20/11/2025
ATLANTA, GA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB:RHEPZ), a self-managed healthcare real [...]
BioSyent Declares Fourth Quarter 2025 Dividend
20/11/2025
MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common [...]
BioSyent Releases Financial Results for Q3 and YTD 2025
20/11/2025
MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key [...]
CHRISTUS Health recognized as ‘Most Wired’ health provider for digital transformation
21/11/2025
IRVING, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CHRISTUS Health has been recognized as a national 2025 “Most Wired” health provider for digital transformation that influences quality and accessibility of care for [...]
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
21/11/2025
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that given the high rate of non- [...]
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
21/11/2025
Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 Program The ability to attract [...]
Seren Advanced Dentistry Oxnard Announces Implementation of Biomimetic Conservative Dentistry Led by Dr. Ette Ntekim
21/11/2025
Oxnard, CA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Seren Advanced Dentistry Oxnard today formally announced the introduction of biomimetic conservative dentistry as part of its restorative care offerings. The announcement [...]
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
21/11/2025
WILMINGTON, Del., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of [...]
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer
20/11/2025
BERKELEY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointment of Robert Brown, [...]
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
20/11/2025
MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and kills cancer cells Activates multiple immune pathways to generate potent, [...]
GENFIT annonce la réalisation du retrait volontaire de ses « American Depositary Shares » du Nasdaq Stock Market
20/11/2025
Lille (France), Cambridge ( Massachusetts, États-Unis), Zurich (Suisse), le 20 novembre 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de [...]
GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
20/11/2025
Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); November 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare [...]
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
20/11/2025
Ghent - Belgium, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM PRESS RELEASE REGULATED INFORMATION – [...]
GENFIT : Information financière du troisième trimestre 2025 et point sur les activités de la Société
20/11/2025
Trésorerie et équivalents de trésorerie s’élevant à 119,0 millions d’euros au 30 septembre 2025 39,2 millions d’euros de revenus pour les neuf premiers mois de 2025, incluant un paiement d’étape de 26,5 millions d’euros [...]
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update
20/11/2025
Cash and cash equivalents totaled €119.0 million as of September 30, 2025 €39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following pricing and [...]
Medx Holdings Posts Strong Q3 Momentum and Reinforces Its Foundation Ahead of 2026 Expansion
20/11/2025
Medx Posts Strong Q3 Reports Austin Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) LazyDaze Posts Strong Q3 Momentum and Reinforces Its Foundation Ahead of 2026 Expansion [...]
DLH to Announce Fiscal 2025 Fourth Quarter Financial Results
20/11/2025
ATLANTA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]

Pages